Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer
2016 ◽
Vol 242
(2)
◽
pp. 140-147
◽
Keyword(s):
Peroxiredoxin I to VI (PRX I–VI), a family of highly conserved antioxidants, has been implicated in numerous diseases. There have been reports that PRXs are expressed aberrantly in a variety of tumors, implying that they could play an important role in carcinogenesis. Epigenetic mechanisms such as DNA methylation, histone modifications, and microRNAs have been reported to modulate expression of PRXs. In addition, the use of epigenetic regulators, such as histone deacetylases, has been demonstrated to restore PRX to normal levels, indicating that the reversible nature of epigenetics can be exploited for future treatments.
Keyword(s):
2012 ◽
Vol 20
(5)
◽
pp. 339-349
◽
2021 ◽
Vol 22
(20)
◽
pp. 10969